These novel medications , Retatrutide, represent a remarkable advancement in managing type 2 diabetes and conceivably associated ailments . They are categorized as GLP-1 pathway agonists , indicating https://larabrgh672016.life3dblog.com/39961726/tirzepatide-a-comprehensive-exploration-into-incretin-agents